Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ: XRAY )

18.48 +0.43 (+2.35%)
Streaming Delayed Price Updated: 10:53 AM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
SHAREHOLDER DEADLINE NOTICE: Scott+Scott Attorneys at Law LLP Notifies Investors that a Securities Class Action Has Been Filed Against Dentsply Sirona, Inc. (NASDAQ: XRAY)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
XRAY Investors Have Opportunity to Lead DENTSPLY SIRONA Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Latest Analyst Ratings For Dentsply Sirona
Via Benzinga
Navigating 6 Analyst Ratings For Dentsply Sirona
Via Benzinga
Analyst Expectations For Dentsply Sirona's Future
Via Benzinga
Dentsply Sirona Inc. Investor Alert: Robbins LLP Reminds XRAY Stockholders of the Pending Class Action
From Robbins LLP
Via GlobeNewswire
DENTSPLY SIRONA INC. (NASDAQ: XRAY) INVESTOR ALERT: Investors With Large Losses in DENTSPLY SIRONA Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
Rosen Law Firm Urges Dentsply Sirona Inc. (NASDAQ: XRAY) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts
Via Benzinga
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Via Benzinga
Key Takeaways From Dentsply Sirona Analyst Ratings
Via Benzinga
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA
From Faruqi & Faruqi LLP
Via GlobeNewswire
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
Via Benzinga
Exposures Fossil Fuels
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Via Benzinga
Gold Gains 1%; Halliburton Posts Weak Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand
Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%. 
Via Benzinga
Topics Earnings
Exposures Financial
Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Know
Via Benzinga
Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demand
Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand. 
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024
XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
XRAY Investors Have the Opportunity to Join Investigation of DENTSPLY SIRONA Inc. with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
7 Long-Term Stocks to Buy Now: May 2024
While anything can happen in the markets from day to day, over the long-term, these seven long-term stocks to buy should prosper regardless. 
Via InvestorPlace
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why
Dentsply Sirona's Q1 disappoints with revenue miss at $953M, down 2.6% YoY; adjusted EPS meets expectations at 42 cents. 
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Meets EPS, Misses Revenue for Q1 2024
XRAY stock results show that Dentsply Sirona met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.